Mayo Clinic's approach


Pancreas transplant consultation at Mayo Clinic Pancreas transplant consultation

Pancreas transplant consultation at Mayo Clinic

At Mayo Clinic, an integrated team of doctors trained in endocrinology (endocrinologists), abdominal transplant surgery, infectious disease management and other specialties is focused on your needs and the needs of your family before, during and after your pancreas transplant.

Surgeons, doctors, transplant nurses, pharmacists, social workers and others work together to manage every aspect of your pancreas transplant, from planning through post-surgical care.

Coordinated care

Care team roles Care team roles

Health care professionals trained in many medical specialties work together as a team to ensure favorable outcomes from your pancreas transplant.

Having all of this subspecialized expertise in a single place, focused on you, means that you're not just getting one opinion — your care is discussed among the team, your test results are available quickly, appointments are scheduled in coordination, and your transplant care team works together to determine what's best for you.

Surgical expertise

Mayo Clinic surgeons have performed hundreds of successful pancreas transplants using state-of-the-art technology since 1987. Across three campuses in Minnesota, Florida and Arizona, Mayo Clinic's expert transplant teams perform more than 50 pancreas transplants a year.

Mayo Clinic is one of only a few transplant centers that offer pancreas transplants to select candidates with type 2 diabetes and treated HIV.

Pancreas transplant surgery is also provided to children at Mayo Clinic's campus in Rochester, Minnesota.


At Mayo Clinic, you may have access to clinical trials, research studies and new treatments as part of your care.

Researchers in the Mayo Clinic Transplant Center are actively engaged in developing new technologies, treatments and techniques to make transplants safer and available to more people.

For example, researchers at Mayo Clinic are developing an artificial pancreas that could significantly improve the quality of life for people with type 1 diabetes and potentially provide an alternative to pancreas transplant.

Mayo Clinic researchers are also investigating ways to lower the rejection risk among transplant recipients and seeking new ways to treat people who need transplants of all types.

Read more about the Pancreas Transplant Program at Mayo Clinic.

Watch Mark Stegall, M.D., and Richard Daly, M.D., discuss lowering rejection risk in organ transplants.

Nationally recognized expertise

Mayo Clinic in Rochester, Minn., ranks No. 1 for diabetes and endocrinology in the U.S. News & World Report Best Hospitals rankings. Mayo Clinic in Scottsdale, Ariz., is ranked highly performing for diabetes and endocrinology by U.S. News & World Report.

Aug. 19, 2017
  1. Klein CL, et al. Patient selection for and immunologic issues relating to kidney-pancreas transplantation in diabetes mellitus. Accessed March 21, 2016.
  2. Klein C, et al. Benefits and complications associated with kidney-pancreas transplantation in diabetes mellitus. Accessed March 21, 2016.
  3. Pancreas transplantation. American Diabetes Association. Accessed March 21, 2016.
  4. Robertson RP. Pancreas and islet transplantation in diabetes mellitus. Accessed March 21, 2016.
  5. Health after transplantation. American Society of Transplantation. Accessed March 22, 2016.
  6. Preparing for the transplant. American Society of Transplantation. Accessed March 22, 2016.
  7. Kidney-pancreas transplant. National Kidney Foundation. Accessed March 22, 2016.
  8. Scientific Registry of Transplant Recipients 2012 Annual Data Report: Pancreas. Health Resources and Services Administration. Accessed April 12, 2016.
  9. Chakkera HA (expert opinion). Mayo Clinic, Phoenix, Arizona. April 12, 2016.
  10. Side effects. UNOS Transplant Living. Accessed March 22, 2016.
  11. Pancreas transplant. National Kidney Foundation. Accessed March 22, 2016.
  12. Heilman RL, et al. Immunosuppression in simultaneous pancreas-kidney transplantation. Drugs. 2010;70:793.
  13. Kandaswamy R, et al. Pancreas. American Journal of Transplantation. 2016;16(suppl 2):47.
  14. Pancreas. Organ Procurement and Transplantation Network. Accessed March 23, 2016.
  15. Barbara Woodward Lips Patient Education Center. Pancreas transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
  16. Pancreas. PubMed Health. Accessed April 7, 2016.
  17. Guidance for industry: Considerations for allogeneic pancreatic islet cell products. U.S. Food and Drug Administration. Accessed March 28, 2016.
  18. Pancreatic islet transplantation. National Institute of Diabetes and Digestive and Kidney Diseases. Accessed March 28, 2016.
  19. Kudva YC, et al. Comprehensive immune monitoring reveals profound immunological changes in pancreas after kidney (PAK) transplant recipients. Human Immunology. 2013;74:738.
  20. Reddy KS, et al. Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: Comparison to induction with antithymocyte globulin. Transplantation Proceedings. 2010;42:2006.
  21. Riggin ER. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 6, 2016.